P
US8729234B2ExpiredUtilityPatentIndex 52

Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism

Assignee: RIEUNIER FRANÇOISPriority: May 10, 2002Filed: Mar 30, 2012Granted: May 20, 2014
Est. expiryMay 10, 2022(expired)· nominal 20-yr term from priority
Inventors:RIEUNIER FRANÇOISFEYSSAGUET MURIELHENRIOT STÉPHANIELAMBERT NADINE
C07K 16/118C07K 14/005C12N 2740/16122C07K 2317/32G01N 2333/16G01N 33/5767C12N 2770/24222G01N 33/56983C12N 2740/16222C07K 14/1833G01N 2333/18C07K 14/161C07K 16/42G01N 33/56988G01N 33/569
52
PatentIndex Score
1
Cited by
27
References
3
Claims

Abstract

The invention relates to a method for detecting, in vitro, an infection with a microorganism, such as the hepatitis C virus, in a biological sample, by simultaneously detecting an antigen of this microorganism and the antibodies against this same antigen, and also to the reagents and kits implementing this method.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A peptide or polypeptide derived from the capsid protein of HCV, bearing at least one intact epitope site and at least one destroyed epitope site, said destroyed epitope site thus being made incapable of being recognized by an anti-capsid antibody, said peptide or polypeptide comprising any one of sequences SEQ ID NO: 4 to SEQ ID NO: 18. 
     
     
       2. A peptide or polypeptide derived from the gag protein of an HIV, bearing at least one intact epitope site and at least one destroyed epitope site, said destroyed epitope site thus being made incapable of being recognized by an anti-gag protein antibody, said peptide or polypeptide comprising the sequence SEQ ID NO: 22. 
     
     
       3. A peptide selected from the group consisting of SEQ ID NO: 4-18 and 22.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.